Welcome to this week’s Chutes and Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good wordor the badfrom your shop to Angus Liu (email) and we will feature it here at the end of each week.
Teva kicks out high-level executives in drastic structure shakeup
Teva
CSO Michael Hayden will leave.
A shakeup at Teva was expected when Kåre Schultz, who pushed for a rejig at Lundbeck, came on board as CEO. Schultz did live up to his reputation with a company-wide restructuring, but at a scope perhaps few had foreseen. The company will combine its generics and specialty medicines into one commercial organization with three geographic segments, and their R&D efforts will also be put together. As a resul…
Read the full article at: https://www.fiercebiotech.com/biotech/chutes-ladders-teva-rejigs-c-suite-amid-major-restructuring